EIKON THERAPEUTICS INC (EIKN) Stock Price, Forecast & Analysis

NASDAQ:EIKN

14.88 USD
+1.1 (+7.98%)
At close: Mar 2, 2026
14.88 USD
0 (0%)
After Hours: 3/2/2026, 7:15:22 PM

EIKN Key Statistics, Chart & Performance

Key Statistics
Market Cap0
Revenue(TTM)N/A
Net Income(TTM)N/A
Shares0
Float0
52 Week HighN/A
52 Week LowN/A
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)N/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPO2026-02-05
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
EIKN short term performance overview.The bars show the price performance of EIKN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 1 -1 2

EIKN long term performance overview.The bars show the price performance of EIKN in the last 1, 2 and 3 years. 1 year 2 years 3 years

The current stock price of EIKN is 14.88 USD.

EIKON THERAPEUTICS INC / EIKN Daily stock chart

EIKN Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to EIKN.


Chartmill TA Rating
Chartmill Setup Rating
EIKN Full Technical Analysis Report

EIKN Financial Highlights


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A
EIKN financials

EIKN Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A
EIKN Analyst EstimatesEIKN Analyst Ratings

EIKN Ownership

Ownership
Inst OwnersN/A
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
EIKN Ownership

EIKN Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
ABBV ABBVIE INC16.13410.174B
AMGN AMGEN INC17.12209.016B
GILD GILEAD SCIENCES INC16.82184.799B
VRTX VERTEX PHARMACEUTICALS INC23.84126.056B
REGN REGENERON PHARMACEUTICALS17.0282.638B
ALNY ALNYLAM PHARMACEUTICALS INC48.5343.982B
INSM INSMED INC N/A31.848B
NTRA NATERA INC N/A28.947B
BIIB BIOGEN INC12.3628.152B
UTHR UNITED THERAPEUTICS CORP17.4421.698B

About EIKN

Company Profile

EIKN logo image Eikon Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Hayward, California. The company went IPO on 2026-02-05. Eikon Therapeutics, Inc. is a United States-based drug discovery and development company. The Company’s platform allows resolution microscopy as well as the advances in biology, chemistry, engineering, and automation. The company tracks and measures the real-time movement of individual proteins in living cells to understanding of disease biology and discover differentiated therapeutics.

Company Info

EIKON THERAPEUTICS INC

230 Harriet Tubman Way

Hayward CALIFORNIA US

Employees: 0

EIKON THERAPEUTICS INC / EIKN FAQ

What does EIKN do?

Eikon Therapeutics Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Hayward, California. The company went IPO on 2026-02-05. Eikon Therapeutics, Inc. is a United States-based drug discovery and development company. The Company’s platform allows resolution microscopy as well as the advances in biology, chemistry, engineering, and automation. The company tracks and measures the real-time movement of individual proteins in living cells to understanding of disease biology and discover differentiated therapeutics.


What is the current price of EIKN stock?

The current stock price of EIKN is 14.88 USD. The price increased by 7.98% in the last trading session.


Does EIKON THERAPEUTICS INC pay dividends?

EIKN does not pay a dividend.


What is the ChartMill technical and fundamental rating of EIKN stock?

EIKN has a ChartMill Technical rating of 3 out of 10.You can find more details on the Technical Analysis and Fundamental Analysis tabs.


Can you provide the sector and industry classification for EIKON THERAPEUTICS INC?

EIKON THERAPEUTICS INC (EIKN) operates in the Health Care sector and the Biotechnology industry.